Diagnostic Imaging: Brain, 5th Edition
This item will be released on 11-13-2025
Covering the entire spectrum of this fast-changing field, Diagnostic Imaging: Brain, fifth edition, is an invaluable resource for neuroradiologists, general radiologists, and trainees―anyone who requires an easily accessible, highly visual reference on today’s brain imaging. Drs. Miral Jhaveri, Karen L. Salzman, and a diverse group of neuroimaging experts provide updated information on more than 300 brain and CNS conditions to help you make informed decisions at the point of care. The text is lavishly illustrated, delineated, and referenced, making it a useful learning tool as well as a handy reference for daily practice.
Covering the entire spectrum of this fast-changing field, Diagnostic Imaging: Brain, fifth edition, is an invaluable resource for neuroradiologists, general radiologists, and trainees―anyone who requires an easily accessible, highly visual reference on today’s brain imaging. Drs. Miral Jhaveri, Karen L. Salzman, and a diverse group of neuroimaging experts provide updated information on more than 300 brain and CNS conditions to help you make informed decisions at the point of care. The text is lavishly illustrated, delineated, and referenced, making it a useful learning tool as well as a handy reference for daily practice.
New to this edition
- The 5th ed of Diagnostic Imaging Brain includes updates related to advances in neuroimaging, including vessel wall imaging, and also next generation photon counting CT that enables a higher spatial resolution and can accurately identify CSF leaks in patients
- In addition there are a dozen+ new diagnoses in place
- COVID
- SLIPPERS
- GFAP Astropathy
- CHANTER syndrome
- Amyloid-related imaging abnormalities( ARIA)
- Diffuse Astrocytoma, *MYB or *MYBL1-Altered • Diffuse Low-Grade Glioma, MAPK Pathway-Altered
- Diffuse Pediatric-Type High-Grade Glioma, H3-Wildtype and IDG-Wildtype
- Myxoid Glioneuronal Tumor • Malignant Glioneuronal Tumor
- The are new chapters on inflammatory and demyelinating diseases, metabolic conditions, and CNS tumors. There is a total revamp in place of the book’s brain tumor categories based on the revised 2021 WHO CNS Classification and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy. The new WHO Classification added major changes which advance the role of molecular diagnostics in CNS tumor classification, and the 5th edition includes updated chapters across the book to reflect these advances
Key Features
- Provides authoritative, comprehensive guidance on both pathology-based and anatomy-based diagnoses to help you diagnose the full range of brain and CNS conditions
- Contains numerous new diagnoses and new chapters on such topics as inflammatory and demyelinating diseases, metabolic conditions, and CNS tumors
- Reflects significantly revised brain tumor categories based on the WHO CNS Classification and the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, including major changes that advance the role of molecular diagnostics in CNS tumor classification
- Discusses key topics such as advances in treatment of Alzheimer’s disease with the approval of monoclonal antibody (MAB) immunotherapy, CNS manifestations of SARS-CoV-2, and recent advances in vessel wall imaging
- Features x,xxx+ high-quality print images (with an additional x,xxx+ images in the complimentary eBook), including radiology images, full-color medical illustrations, clinical photographs, and gross pathology and histology images
- Increases your ability to communicate imaging findings effectively with other neuroscientists, including oncologists and neurosurgeons
- Uses succinct bulleted text and highly templated chapters for quick comprehension of essential information at the point of care
- Includes an eBook that allows you access to everything in the print version as well as new text, 175 videos, and thousands of additional images and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud; additional digital ancillary content may publish up to 6 weeks following the publication date
Author Information
By Miral D. Jhaveri, MD, MBA, Professor, Division Head, Neuroradiology, Executive Vice-Chair, Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois, USA and Karen L. Salzman, MD, FACR, Professor of Radiology and Imaging Sciences, Neuroradiology Section Chief and Associate Fellowship Director, Leslie W. Davis Endowed Chair in Neuroradiology, University of Utah School of Medicine, Salt Lake City, Utah, USA
